Direct deal-making by ultra-wealthy family investment firms climbed by roughly 30% in October to 56 completed transactions, rebounding from a sluggish September. Healthcare solidified its position as a primary sector of interest, ranking second only to artificial intelligence according to recent wealth survey metrics. Prominent entities including Emerson Collective and Pivotal Ventures directed significant resources toward platforms specializing in Medicaid-backed family care, regional healthcare expansion, and female-specific medical research.
Key points
Healthcare ranks as the second-most-popular sector for direct family office capital deplo…: Healthcare ranks as the second-most-popular sector for direct family office capital deployments, trailing only artificial intelligence.
Investment firms are targeting under-researched market sectors, including female-specific…: Investment firms are targeting under-researched market sectors, including female-specific medical studies and AI training datasets for health research.
Caregiving models relying on Medicare and Medicaid are attracting private investment to p…: Caregiving models relying on Medicare and Medicaid are attracting private investment to professionalize family-led at-home services.
Sources checked by our analysis pipeline: 1
A version of this article appeared in CNBC's Inside Wealth newsletter, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox.
After a slow September, investment firms of ultra-wealthy families stepped up their deal-making last month. In October, family offices made 56 direct investments in companies, up about 30% from the month prior, according to data provided exclusively to CNBC by Fintrx, a private wealth intelligence platform.
Laurene Powell Jobs' Emerson Collective was the most prolific investor of the month, backing three healthcare startups according to Fintrx data. Her investment and philanthropy firm seeks to address health equity and other complex challenges like the energy transition.
Last month, Emerson Collective joined a $555 million Series G for Devoted Health, a healthcare provider and insurer of Medicare Advantage plans, alongside information technology billionaire Azim Premji's namesake family office. Devoted Health, which has counted Emerson Collective as an investor since 2021, announced that it will use the fundraise to expand to five additional states for a total of 34.
The Department of Defense is targeting foreign supply chain dependencies by backing a manufacturing facility in Tennessee designed to bypass Chinese components. Founded twelve years ago in Massachusetts, 6K will establish advanced production capabilities to support both military hardware and commercial applications. The project provides critical federal momentum after previous clean energy financing efforts suffered major regulatory setbacks.
Leadership changes across the life sciences sector continue to shuffle top clinical talent between emerging biotech firms. Sarah Browne steps into an executive role overseeing clinical strategy after accumulating industry experience in both advisory and operational capacities. Her appointment brings established drug development leadership to the company.
The Spanish infrastructure group is considering a deal to absorb the remaining shares of its construction arm in Germany. Pursuing this full integration would consolidate the parent company's operational footprint across key European and international markets. The strategic maneuver is currently under evaluation as reported by Bloomberg News.